AltheaDx: Castle Biosciences Completes Acquisition of AltheaDx
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has completed its acquisition of AltheaDx, Inc. (AltheaDx).
Read full article »
AltheaDx is a California-based commercial-stage molecular diagnostics company that offers pharmacogenomics testing services for patients and clinicians.
Read more